Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Randomization	STARTED	Selatogrel 8 mg	25
Randomization	STARTED	Selatogrel 16 mg	23
Randomization	COMPLETED	Selatogrel 8 mg	24
Randomization	COMPLETED	Selatogrel 16 mg	23
Randomization	NOT COMPLETED	Selatogrel 8 mg	1
Randomization	NOT COMPLETED	Selatogrel 16 mg	0
Treatment Period	STARTED	Selatogrel 8 mg	24
Treatment Period	STARTED	Selatogrel 16 mg	23
Treatment Period	Modified Full Analysis Set (mFAS)	Selatogrel 8 mg	23
Treatment Period	Modified Full Analysis Set (mFAS)	Selatogrel 16 mg	22
Treatment Period	Per Protocol Set	Selatogrel 8 mg	20
Treatment Period	Per Protocol Set	Selatogrel 16 mg	20
Treatment Period	COMPLETED	Selatogrel 8 mg	24
Treatment Period	COMPLETED	Selatogrel 16 mg	23
Treatment Period	NOT COMPLETED	Selatogrel 8 mg	0
Treatment Period	NOT COMPLETED	Selatogrel 16 mg	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03487445/flow